ACTRN12621001368820招募中未知
Efficacy in pharmacogenomics in guiding mental health treatment in patients with major depressive disorder and/or anxiety disorders
St Vincent's Health Australia0 个研究点目标入组 80 人开始时间: 2021年10月11日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 16 Years 至 70 Years（—）
- 性别
- All
入选标准
- •1.Aged between 16 years and 70 years inclusive
- •2.Have a diagnosis of a Major Depressive Disorder (MDD) and/or Anxiety Disorder requiring psychotropic medications (either antidepressants or antipsychotics, or both) as part of their standard care
- •3.Are either new to psychotropic medication treatment or had psychotropic medication changes in the last three months
- •4.Sufficiently fluent in English
- •5.Have both mental and intellectual capacity to provide written or verbal informed consent
- •6.Willingness to participate in study and complete survey questions
- •7.Willingness to undergo PG genetic testing
- •8.Willingness to consider PG-guided psychotropic medication treatment prescribed by treating psychiatrist
- •Participants with a stable psychotic disorder as a psychiatric comorbidity will not be excluded.
- •Participants who are receiving other treatment, such as electroconvulsive therapy (ECT) and/or other medications, will not be excluded.
排除标准
- •1.Significant suicidal risk
- •2.Mental, cognitive or intellectual impairment interfering with capacity to consent
- •3.Unwilling to comply with study schedule and requirements
研究者
相似试验
已完成
不适用
Effectiveness of the psychological and pharmacological treatment of catastrophisation in patients with fibromyalgia: a controlled randomised trialFibromyalgiaISRCTN10804772The Carlos III Health Institute (Instituto de Salud Carlos III) (Spain)180
撤回
4 期
Clinical Utility of Pharmacogenomics of Psychotropic MedicationsPsychiatric DisordersPainNCT03907124Oregon Health and Science University
尚未招募
不适用
Clinical utility of genetic testing based treatment of depression in India as per recommendations of international guidelinesCTRI/2022/08/044982Indian Council of Medical Research
终止
4 期
Combinatorial Pharmacogenomics Testing in Treatment-Naïve Major Depressive DisorderDepressive DisorderMajor Depressive DisorderDepressive EpisodeDepression, UnipolarDepressionNCT03537547Washington University School of Medicine6
招募中
Unknown
A study on the effects of pharmacotherapy and psychosocial treatment of somatic symptom disorders in the orofacial region (e.g. burning mouth syndrome, temporomandibular disorder, and persistent idiopathic facial pain) using personality tendencies, nurturing experiences, and support from others as indicators.somatic symptom disorders in the orofacial regionJPRN-UMIN000050995Department of Oral and Maxillofacial Surgery, School of Dentistry, Aichi Gakuin University500